0.63 USD
↗ 0.02 (2.59%)PRE MARKET (AS OF 06:48 AM EDT)
Enlivex Ltd. Ordinary Shares
ENLVNASDAQ • USD
Market: OPEN
ENLV is currently priced at $0.63. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, ENLV trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 17, 2026.
Open?$0.62
High?$0.63
Low?$0.62
Prev. Close?$0.62
Volume?586
Avg. Volume?367.5K
VWAP?$0.63
Rel. Volume?0.00x
Bid / Ask
Bid?$0.54 × 100
Ask?$0.75 × 100
Spread?$0.21
Midpoint?$0.64
Valuation & Ratios
Market Cap?149.5M
Shares Out?241.0M
Float?32.2M
Float %?13.3%
P/E Ratio?N/A
P/B Ratio?4.21
EPS?-$0.03
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?90
Piotroski F-Score?0/9Weak
Altman Z-Score?6.84Safe
Confidence?33%Very Low
Short InterestLow
Short % of Float?1.30%Low
Short Interest?417.8K
Days to Cover?1.0
Free Float32.2M
Avg Daily Volume461.6K
Settlement Date2026-05-29
Financial Health
Current Ratio?1.85Adequate
Quick Ratio?1.85Adequate
Cash Ratio?1.30Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.21FAIR▾
Peers100
S&P43
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-13.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-23.7%WEAK▾
S&P7
ROA?-20.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$143.8M
Fundamentals ratios updated end of day